Top Liquid Biopsy Companies in the U.S. (2025)
02 Jul, 2025

The United States liquid biopsy market is expected to be around US$ 4.25 billion by 2033. It is expected to grow at a robust CAGR of 14.99% from 2025 to 2033, from US$ 1.21 billion in 2024. The market for liquid biopsies in the United States is expanding quickly due to the rise in cancer incidence and improvements in non-invasive diagnostic methods. A less intrusive option to conventional tissue biopsies is provided by liquid biopsy assays, which examine indicators such circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) from blood samples. These tests are becoming more popular for diagnosing minimum residual disease (MRD), tracking therapy responses, and early cancer diagnosis. At the forefront are businesses like Exact Sciences, Natera, and Guardant Health, who are creating diagnostics that can detect cancer recurrence months before conventional imaging techniques can. The market's trend indicates that liquid biopsies will become more and more important in individualized cancer therapy, even if there are still obstacles to overcome, such as the requirement for wider insurance coverage and validation across a range of groups.

Discover key trends, growth opportunities, and major challenges shaping the United States Liquid Biopsy Industry in Renub Research’s latest in-depth market report. Download your free sample now

List of Leading Companies in the United States Liquid Biopsy Market

1.Thermo Fisher Scientific Inc.

Establishment: 2006

Headquarters: United States of America

Website: www.thermofisher.com

Revenue: $42.9B in 2023

Thermo Fisher Scientific Inc. (Thermo Fisher) provides laboratory, pharmaceutical, biotechnology, and specialty diagnostic services in addition to analytical tools and life sciences solutions. Chemicals, cell culture materials, tools for analyzing proteins and cells, clinical and diagnostic tools, chromatography and mass spectrometry devices, laboratory supplies, equipment, instruments, and goods for molecular biology and nucleic acid analysis are among its offerings. Through the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD brands, the corporation distributes its goods to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research organizations, and government agencies. It uses a direct sales force, customer care agents, online sales, and independent distributors to sell its goods. The US city of Waltham, Massachusetts, is home to Thermo Fisher's headquarters.

2.  Roche Diagnostics

Establishment: 1896

Headquarters: Switzerland

Website: www.roche.ch/en/sites/rotkreuz/about-roche-diagnostics-international

Clinics, labs, and physician offices can obtain diagnostic system solutions from Roche Diagnostics International Ltd (Roche Diagnostics), a division of F. Hoffmann-La Roche Ltd. The business creates, manufactures, and maintains software and equipment systems for in-vitro diagnostics and bioanalytical research. Additionally, it provides molecular diagnostic reagents, test systems, workflow solutions, and diagnostic analysis systems. Blood glucose meters and point-of-care testing equipment are among its main offerings. Hospitals, commercial diagnostic labs, medical professionals, researchers, and pharmacists are among the clients the firm serves with its goods and services. The headquarters of Roche Diagnostics are located in Rotkreuz, Switzerland.

3.  Bio-Rad Laboratories Inc.

Establishment: 1952

Headquarters: United States of America

Website: www.bio-rad.com

Revenue: $2.6B in 2023

Instruments, software, consumables, and reagents are developed, produced, and marketed by Bio-Rad Laboratories Inc. (Bio-Rad) for use in clinical diagnostics and life science research. Among its products are digital PCR, blood type and antibody detection systems, antibodies, autoimmune testing kits, and equipment for cell isolation and analysis. Among other fields, the company's products are used in immunology, gene expression analysis, cell research, bioprocess analytics, and mutation detection. It provides services to hospitals, public health and commercial laboratories, universities and research organizations, diagnostic manufacturers, and businesses in the food, chemical, pharmaceutical, and biotechnology sectors. Bio-Rad distributes its goods via distributors, agencies, brokers, resellers, and direct sales channels. Among other places, the business operates in the US, Germany, France, China, and Singapore. The US city of Hercules, California, is home to Bio-Rad's headquarters.

4.  Biocept, Inc.

Establishment: 1997

Headquarters: United States of America

Website: http://www.biocept.com

The firm Biocept Inc. (Biocept) specializes in molecular diagnostics. Using a typical blood sample, it creates and markets proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. Breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer are among the solid tumor indications for which the firm provides tests. Biocept provides OncoCEE technology, associated instruments, and analytical tools for genetic characterisation and uncommon event identification. Rare cell collection and analysis techniques are modified by the company's OncoCEE, Target Selector, and CEE-Sure platforms. Additionally, it provides oncologists and other medical professionals, hospitals, and cancer centers with cancer diagnostic tests. Additionally, Biocept offers research and clinical trial services to clinical research institutions as well as pharmaceutical and biopharmaceutical firms. The US city of San Diego, California, is home to Biocept's headquarters.

5.  Biocartis

Establishment: 2007

Headquarters: Mechelen, Belgium

Website: http://www.biocartis.com

With its own IdyllaTM Platform, Biocartis is a cutting-edge molecular diagnostics firm dedicated to transforming molecular testing. With an emphasis on cancer, we offer next-generation diagnostic solutions that are intended to enhance clinical practice for the benefit of patients, physicians, payers, and the healthcare sector. Tests for melanoma, colorectal, lung, breast, thyroid, brain, and blood cancer are now available from Biocartis.

6.  Myriad Genetics, Inc.

Establishment: 1991

Headquarters: United States of America

Website: www.myriad.com

Revenue: $837.6M in 2023

Myriad Genetics Inc. (Myriad) is a corporation that develops and tests molecular diagnostics. For cancer risk, family planning, mental health, oncology, prenatal care, primary care, and urology, the firm creates and provides molecular tests that evaluate disease risk, inform treatment choices, and improve patient care. Among its main offerings are genetic tests and screenings, including pharmacogenomic testing, tumor testing, germline testing, prenatal screening, fetal sex determination, and carrier screens. Healthcare professionals from a variety of medical specializations utilize the company's products to identify, treat, and prevent illnesses in their patients. It runs production plants throughout the United States. The US city of Salt Lake City, Utah, is home to Myriad's headquarters.

7.  Exact Sciences (Genomic Health)

Establishment: 1995

Headquarters: United States of America

Website: www.exactsciences.com

Revenue: $2.8B in 2023

The molecular diagnostic business Exact Sciences Corp (Exact Sciences) is dedicated to creating assays for different kinds of cancer. The Cologuard test, the company's main offering, is a non-invasive stool-based deoxyribonucleic acid (DNA) screening tool that has been authorized by the US FDA and is recommended for the early diagnosis of colorectal cancer and pre-cancer. It looks for hemoglobin and DNA biomarkers linked to colorectal cancer using a multi-target strategy. The business also sells the Oncotype DX AR-V7 Nucleus Detect test, a liquid-based test for advanced stage prostate cancer, and Oncotype DX gene expression tests for prostate, breast, and colon cancers. To handle Cologuard tests, it has manufacturing and lab facilities in Madison, Wisconsin. The US city of Madison, Wisconsin, is home to Exact Sciences' headquarters.

8.  NeoGenomics Laboratories

Establishment: 2002

Headquarters: United States of America

Website: neogenomics.com

Revenue: $660.0M in 2023

NeoGenomics Inc. (NeoGenomics) is a pharmaceutical and cancer diagnostics firm that provides prognostic, predictive, and diagnostic testing services.  Among the services the business provides are diagnostic, specialty testing, tech-only program, lab, and clinical services.  Methodologies, anatomic pathology, cytogenetics, flow cytometry, fluorescence in situ hybridization (FISH), and next-generation sequencing are examples of diagnostic services.  Hereditary cancer, liquid biopsies, and early-stage non-small cell lung cancer (NSCLC) panels are among the specialty diagnostic options offered.  Molecular, flow cytometry, multiplexed immunofluorescence, and chimeric antigen receptor (CAR) T services are examples of lab services.  The US company NeoGenomics is based in Fort Myers, Florida.

9.  Quest Diagnostic Inc.

Establishment: 1967

Headquarters: United States of America

Website: www.questdiagnostics.com

Revenue: $9.9B in 2023

Through a network of labs and company-owned patient service centers, Quest Diagnostics Inc. (Quest Diagnostics) is a healthcare organization that offers diagnostic information services to doctors and patients. Clinical testing including gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurance services, and a variety of healthcare information technology and diagnostic products are just a few of the many services it provides. In a variety of healthcare industries, doctors, hospitals, patients, health insurance, and government organizations use the company's goods and services. Through a network of labs and patient care facilities, Quest Diagnostics does business. The business operates in Europe, South America, Asia Pacific, and North America. The headquarters of Quest Diagnostics are located in Secaucus, New Jersey, in the United States.